|

N17350 Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Pipeline

Phase 1/2: 1

Top Sponsors

  • Onchilles Pharma Inc1

Indications

  • Breast Neoplasms, Triple-Negative1
  • Neoplasms, Solid Tumor1
  • Squamous Cell Carcinoma of Skin1
  • Carcinoma, Squamous Cell1
  • Carcinoma, Non-Small-Cell Lung1

Los Angeles, California1 trial

Intratumoral N17350 in Advanced Solid Tumors

The Angeles Clinic and Research Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.